🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
4.500
-0.260 (-5.46%)
At close: Nov 19, 2026, 4:00 PM EST
4.240
-0.260 (-5.78%)
After-hours: Nov 19, 2026, 7:59 PM EST

Cue Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
57.9427.1422.4648.5151.6164.37
Short-Term Investments
0.051.090.930.2924.68-
Cash & Short-Term Investments
57.9928.2323.3948.876.2964.37
Cash Growth
183.98%20.70%-52.08%-36.03%18.52%-24.15%
Accounts Receivable
5.135.550.951.70.063.14
Other Receivables
-1.9----
Receivables
5.137.450.951.70.063.14
Prepaid Expenses
1.691.310.810.960.840.87
Other Current Assets
1.9----0.08
Total Current Assets
66.7136.9825.1451.4577.1968.47
Property, Plant & Equipment
0.234.324.847.1210.711.92
Other Long-Term Assets
0.320.912.212.963.393.01
Total Assets
67.2642.2132.1961.5391.2883.4

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
3.613.952.823.52.732.59
Accrued Expenses
15.191.612.914.143.554.62
Current Portion of Long-Term Debt
--4.333.961.96-
Current Portion of Leases
-1.913.543.373.34.93
Current Unearned Revenue
-5.340.092.11-0.65
Other Current Liabilities
0.930.69---0
Total Current Liabilities
19.7313.4913.6917.0811.5512.79
Long-Term Debt
---4.28.04-
Long-Term Leases
-2.2913.166.025.12
Other Long-Term Liabilities
9.13-----
Total Liabilities
28.8615.7814.6924.4525.617.91

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.10.060.050.040.03
Additional Paid-In Capital
615.12394.8359.3338.23316.19262.91
Retained Earnings
-576.73-368.47-341.86-301.19-250.46-197.45
Comprehensive Income & Other
-----0.1-
Shareholders' Equity
38.426.4317.537.0965.6865.49
Total Liabilities & Equity
67.2642.2132.1961.5391.2883.4

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-4.28.8814.719.3210.05
Net Cash (Debt)
57.9924.0314.5134.1156.9754.32
Net Cash Growth
307.03%65.60%-57.45%-40.14%4.89%-30.11%
Net Cash Per Share
9.147.617.7322.3647.9452.09
Filing Date Shares Outstanding
8.363.262.061.621.441.1
Total Common Shares Outstanding
7.753.222.061.571.431.07
Working Capital
46.9823.4911.4534.3765.6455.68
Book Value Per Share
4.958.218.4923.5645.7861.01
Tangible Book Value
38.426.4317.537.0965.6865.49
Tangible Book Value Per Share
4.958.218.4923.5645.7861.01
Machinery
-3.794.034.295.625.55
Leasehold Improvements
-0.120.120.120.120.01
SEC Filings: 10-K · 10-Q